WO2010073248A2 - Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux - Google Patents
Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux Download PDFInfo
- Publication number
- WO2010073248A2 WO2010073248A2 PCT/IL2009/001212 IL2009001212W WO2010073248A2 WO 2010073248 A2 WO2010073248 A2 WO 2010073248A2 IL 2009001212 W IL2009001212 W IL 2009001212W WO 2010073248 A2 WO2010073248 A2 WO 2010073248A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- nucleic acid
- origin
- acid sequence
- sample
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980157378XA CN102333888B (zh) | 2008-12-24 | 2009-12-23 | 用于肿瘤样本起源组织分类的基因表达签名 |
IL212979A IL212979A (en) | 2008-12-24 | 2011-05-18 | Gene expression signature to classify the source tissue of cancer tumor samples |
US13/167,489 US8802599B2 (en) | 2007-03-27 | 2011-06-23 | Gene expression signature for classification of tissue of origin of tumor samples |
US13/856,190 US9096906B2 (en) | 2007-03-27 | 2013-04-03 | Gene expression signature for classification of tissue of origin of tumor samples |
US14/320,113 US20140315739A1 (en) | 2007-03-27 | 2014-06-30 | Gene expression signature for classification of tissue of origin of tumor samples |
US14/746,487 US20150368724A1 (en) | 2007-03-27 | 2015-06-22 | Methods and materials for classification of tissue of origin of tumor samples |
US15/853,258 US20180127835A1 (en) | 2007-03-27 | 2017-12-22 | Gene expression signature for classification of tissue of origin of tumor samples |
US15/909,145 US20190032142A1 (en) | 2007-03-27 | 2018-03-01 | Methods and materials for classification of tissue of origin of tumor samples |
US16/226,406 US20190241966A1 (en) | 2007-03-27 | 2018-12-19 | Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14064208P | 2008-12-24 | 2008-12-24 | |
US61/140,642 | 2008-12-24 |
Related Parent Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2008/000396 Continuation-In-Part WO2008117278A2 (fr) | 2007-03-27 | 2008-03-20 | Signature d'une expression génique permettant la classification des cancers |
US12/532,940 Continuation-In-Part US20100178653A1 (en) | 2007-03-27 | 2008-03-20 | Gene expression signature for classification of cancers |
US53294009A Continuation-In-Part | 2007-03-27 | 2009-09-24 | |
PCT/IL2011/000849 Continuation-In-Part WO2012070037A2 (fr) | 2007-03-27 | 2011-11-01 | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/167,489 Continuation-In-Part US8802599B2 (en) | 2007-03-27 | 2011-06-23 | Gene expression signature for classification of tissue of origin of tumor samples |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010073248A2 true WO2010073248A2 (fr) | 2010-07-01 |
WO2010073248A3 WO2010073248A3 (fr) | 2010-09-16 |
Family
ID=42288202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2009/001212 WO2010073248A2 (fr) | 2007-03-27 | 2009-12-23 | Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102333888B (fr) |
WO (1) | WO2010073248A2 (fr) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011154008A1 (fr) * | 2010-06-11 | 2011-12-15 | Rigshospitalet | Classification de micro-arn de néoplasie folliculaire de la thyroïde |
WO2012010584A1 (fr) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Ensembles de miarn complexes en tant que nouveaux biomarqueurs pour le cancer gastrique |
WO2012070037A2 (fr) | 2010-11-22 | 2012-05-31 | Rosetta Genomics Ltd. | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
WO2012089630A1 (fr) | 2010-12-30 | 2012-07-05 | Fondazione Istituto Firc Di Oncologia Molecolare (Ifom) | Méthode d'identification d'individus asymptomatiques à haut risque ayant un cancer des poumons à un stade précoce grâce à la détection de mirnas dans les fluides biologiques |
WO2012145129A3 (fr) * | 2011-04-18 | 2013-02-07 | Cornell University | Sous-typage moléculaire, pronostic et traitement du cancer de la prostate |
US8541170B2 (en) | 2008-11-17 | 2013-09-24 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
EP2653558A1 (fr) * | 2012-04-18 | 2013-10-23 | Roche Diagniostics GmbH | Procédé de détection de cibles d'acide nucléique à l'aide d'un classificateur statistique |
JP2013544098A (ja) * | 2010-11-17 | 2013-12-12 | アシュラジェン インコーポレイテッド | 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのmiRNA |
US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
US8831327B2 (en) | 2011-08-30 | 2014-09-09 | General Electric Company | Systems and methods for tissue classification using attributes of a biomarker enhanced tissue network (BETN) |
US20140309123A1 (en) * | 2011-03-28 | 2014-10-16 | Rosetta Genomics Ltd. | Methods for lung cancer classification |
US9096906B2 (en) | 2007-03-27 | 2015-08-04 | Rosetta Genomics Ltd. | Gene expression signature for classification of tissue of origin of tumor samples |
JP6011945B2 (ja) * | 2011-05-20 | 2016-10-25 | 公一 中城 | マイクロrna又はその発現系を含む組成物 |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
EP3369818A1 (fr) * | 2011-12-22 | 2018-09-05 | InteRNA Technologies B.V. | Miarn permettant le traitement du cancer de la tête et du cou |
US10114924B2 (en) | 2008-11-17 | 2018-10-30 | Veracyte, Inc. | Methods for processing or analyzing sample of thyroid tissue |
US10422009B2 (en) | 2009-03-04 | 2019-09-24 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
US10865452B2 (en) | 2008-05-28 | 2020-12-15 | Decipher Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
US11078542B2 (en) | 2017-05-12 | 2021-08-03 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
US11208697B2 (en) | 2017-01-20 | 2021-12-28 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
US11639527B2 (en) | 2014-11-05 | 2023-05-02 | Veracyte, Inc. | Methods for nucleic acid sequencing |
US11873532B2 (en) | 2017-03-09 | 2024-01-16 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110706749B (zh) * | 2019-09-10 | 2022-06-10 | 至本医疗科技(上海)有限公司 | 一种基于组织器官分化层次关系的癌症类型预测系统和方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050059005A1 (en) * | 2001-09-28 | 2005-03-17 | Thomas Tuschl | Microrna molecules |
US20060084056A1 (en) * | 2002-02-13 | 2006-04-20 | Nadia Harbeck | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20070083945A1 (en) * | 2000-03-10 | 2007-04-12 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US20080076674A1 (en) * | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
US20080305962A1 (en) * | 2005-07-29 | 2008-12-11 | Ralph Markus Wirtz | Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies |
-
2009
- 2009-12-23 CN CN200980157378XA patent/CN102333888B/zh active Active
- 2009-12-23 WO PCT/IL2009/001212 patent/WO2010073248A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070083945A1 (en) * | 2000-03-10 | 2007-04-12 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US20050059005A1 (en) * | 2001-09-28 | 2005-03-17 | Thomas Tuschl | Microrna molecules |
US20060084056A1 (en) * | 2002-02-13 | 2006-04-20 | Nadia Harbeck | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20080305962A1 (en) * | 2005-07-29 | 2008-12-11 | Ralph Markus Wirtz | Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies |
US20080076674A1 (en) * | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
Non-Patent Citations (1)
Title |
---|
SCHULTZ ET AL.: 'MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorageindependent growth.' CELL RES. vol. 18, no. 5, May 2008, pages 549 - 57 * |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9096906B2 (en) | 2007-03-27 | 2015-08-04 | Rosetta Genomics Ltd. | Gene expression signature for classification of tissue of origin of tumor samples |
US10865452B2 (en) | 2008-05-28 | 2020-12-15 | Decipher Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
US8541170B2 (en) | 2008-11-17 | 2013-09-24 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
US10672504B2 (en) | 2008-11-17 | 2020-06-02 | Veracyte, Inc. | Algorithms for disease diagnostics |
US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
US10114924B2 (en) | 2008-11-17 | 2018-10-30 | Veracyte, Inc. | Methods for processing or analyzing sample of thyroid tissue |
US10422009B2 (en) | 2009-03-04 | 2019-09-24 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
US10934587B2 (en) | 2009-05-07 | 2021-03-02 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
US10731223B2 (en) | 2009-12-09 | 2020-08-04 | Veracyte, Inc. | Algorithms for disease diagnostics |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
US9856537B2 (en) | 2009-12-09 | 2018-01-02 | Veracyte, Inc. | Algorithms for disease diagnostics |
WO2011154008A1 (fr) * | 2010-06-11 | 2011-12-15 | Rigshospitalet | Classification de micro-arn de néoplasie folliculaire de la thyroïde |
WO2012010584A1 (fr) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Ensembles de miarn complexes en tant que nouveaux biomarqueurs pour le cancer gastrique |
JP2013544098A (ja) * | 2010-11-17 | 2013-12-12 | アシュラジェン インコーポレイテッド | 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのmiRNA |
US10150999B2 (en) | 2010-11-17 | 2018-12-11 | Interpace Diagnostics, Llc | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms |
US11118231B2 (en) | 2010-11-17 | 2021-09-14 | Interpace Diagnostics, Llc | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms |
EP2772550B1 (fr) | 2010-11-17 | 2017-03-29 | Interpace Diagnostics, LLC | Micro-ARN comme biomarqueurs pour différencier des néoplasmes de thyroïde bénins et malins |
EP2643479A2 (fr) * | 2010-11-22 | 2013-10-02 | Rosetta Genomics Ltd | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
WO2012070037A2 (fr) | 2010-11-22 | 2012-05-31 | Rosetta Genomics Ltd. | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
EP2643479A4 (fr) * | 2010-11-22 | 2014-08-27 | Rosetta Genomics Ltd | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
WO2012089630A1 (fr) | 2010-12-30 | 2012-07-05 | Fondazione Istituto Firc Di Oncologia Molecolare (Ifom) | Méthode d'identification d'individus asymptomatiques à haut risque ayant un cancer des poumons à un stade précoce grâce à la détection de mirnas dans les fluides biologiques |
US20140309123A1 (en) * | 2011-03-28 | 2014-10-16 | Rosetta Genomics Ltd. | Methods for lung cancer classification |
US9914972B2 (en) * | 2011-03-28 | 2018-03-13 | Rosetta Genomics Ltd. | Methods for lung cancer classification |
EP2505663A1 (fr) | 2011-03-30 | 2012-10-03 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Procédé pour identifier des individus asymptomatiques à haut risque touchés par un cancer du poumon à l'état précoce au moyen de la détection d'ARNmi dans les liquides corporels |
WO2012145129A3 (fr) * | 2011-04-18 | 2013-02-07 | Cornell University | Sous-typage moléculaire, pronostic et traitement du cancer de la prostate |
JP6011945B2 (ja) * | 2011-05-20 | 2016-10-25 | 公一 中城 | マイクロrna又はその発現系を含む組成物 |
US8831327B2 (en) | 2011-08-30 | 2014-09-09 | General Electric Company | Systems and methods for tissue classification using attributes of a biomarker enhanced tissue network (BETN) |
EP3369818A1 (fr) * | 2011-12-22 | 2018-09-05 | InteRNA Technologies B.V. | Miarn permettant le traitement du cancer de la tête et du cou |
EP2653558A1 (fr) * | 2012-04-18 | 2013-10-23 | Roche Diagniostics GmbH | Procédé de détection de cibles d'acide nucléique à l'aide d'un classificateur statistique |
US9399794B2 (en) | 2012-04-18 | 2016-07-26 | Roche Molecular Systems, Inc. | Method of detecting nucleic acid targets using a statistical classifier |
US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
US11639527B2 (en) | 2014-11-05 | 2023-05-02 | Veracyte, Inc. | Methods for nucleic acid sequencing |
US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
US11208697B2 (en) | 2017-01-20 | 2021-12-28 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
US11873532B2 (en) | 2017-03-09 | 2024-01-16 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
US11078542B2 (en) | 2017-05-12 | 2021-08-03 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
Also Published As
Publication number | Publication date |
---|---|
WO2010073248A3 (fr) | 2010-09-16 |
CN102333888B (zh) | 2013-07-10 |
CN102333888A (zh) | 2012-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190241966A1 (en) | Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples | |
WO2010073248A2 (fr) | Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux | |
US9803247B2 (en) | MicroRNAs expression signature for determination of tumors origin | |
WO2008117278A2 (fr) | Signature d'une expression génique permettant la classification des cancers | |
US9096906B2 (en) | Gene expression signature for classification of tissue of origin of tumor samples | |
US9133522B2 (en) | Compositions and methods for the diagnosis and prognosis of mesothelioma | |
WO2009153775A2 (fr) | Procédés permettant de différencier différents types de cancers du poumon | |
US9914972B2 (en) | Methods for lung cancer classification | |
US9068232B2 (en) | Gene expression signature for classification of kidney tumors | |
EP2643479A2 (fr) | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux | |
US9834821B2 (en) | Diagnosis and prognosis of various types of cancers | |
WO2010004562A2 (fr) | Procédés et compositions permettant de détecter un cancer colorectal | |
WO2009066291A2 (fr) | Signature d'expression de micro-arn pour la détermination de l'origine de tumeurs | |
US9340823B2 (en) | Gene expression signature for classification of kidney tumors | |
WO2011039757A2 (fr) | Compositions et méthodes de pronostic du cancer du rein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980157378.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09834226 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 212979 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09834226 Country of ref document: EP Kind code of ref document: A2 |